Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sharon

Showing results (251-260 of 292) with videos related to

Pageof 30
Sort By:
Nature Communications|November 5, 2022
CD8<sup>+</sup> T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Nature Immunology|November 4, 2025
Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsivenessXiaorui Han, Valeria Skatova, Artem Mikelov, et al.
Journal of the American Academy of Dermatology|June 2, 2026
Management of Post-Procedure Eruptive Keratoacanthomas: A Retrospective Cohort StudyJoycie Chang, Drake C Carter, Doroteja Dragovic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2020
Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral ImmunotherapyBenjamin L Wright, Nielsen Q Fernandez-Becker, Neeraja Kambham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2026
Corrigendum to 'Skin as the target for allergy prevention and treatment' [Annals of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133-143]Andreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
Frontiers in Immunology|December 8, 2018
Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut AllergyBenjamin L Wright, Nielsen Q Fernandez-Becker, Neeraja Kambham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 22, 2024
Skin as the target for allergy prevention and treatmentAndreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
Frontiers in Immunology|November 7, 2025
Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy studySayantani B Sindher, Andrea Fernandes, Monali Manohar, et al.
Pageof 30

Showing results (251-260 of 292) with videos related to

Sort By:
Pageof 30
Nature Communications|November 5, 2022
CD8<sup>+</sup> T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Nature Immunology|November 4, 2025
Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsivenessXiaorui Han, Valeria Skatova, Artem Mikelov, et al.
Journal of the American Academy of Dermatology|June 2, 2026
Management of Post-Procedure Eruptive Keratoacanthomas: A Retrospective Cohort StudyJoycie Chang, Drake C Carter, Doroteja Dragovic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2020
Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral ImmunotherapyBenjamin L Wright, Nielsen Q Fernandez-Becker, Neeraja Kambham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2026
Corrigendum to 'Skin as the target for allergy prevention and treatment' [Annals of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133-143]Andreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
Frontiers in Immunology|December 8, 2018
Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut AllergyBenjamin L Wright, Nielsen Q Fernandez-Becker, Neeraja Kambham, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 22, 2024
Skin as the target for allergy prevention and treatmentAndreina Marques-Mejias, Irene Bartha, Christina E Ciaccio, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
Frontiers in Immunology|November 7, 2025
Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy studySayantani B Sindher, Andrea Fernandes, Monali Manohar, et al.
Pageof 30